Timing: when drinking is most and least tolerable Two windows matter
NINA MOINI: Do you have a sense for how big of a cost barrier there is for seniors right now
Unlike sedative drugs that chemically suppress brain activity, DSIP is believed to interact with the bodys own neuroendocrine systems
Importantly, removal from one list does not, by itself, authorize compounding a compounding pathway depends on the outcome of formal review and rulemaking
A higher concentration is not always better
To qualify for Wegovy, youll typically need one of the following: A BMI of 30 or higher (classified as obesity ), or A BMI of 27 or higher with at least one weight-related health condition Weight-related conditions may include: High blood pressure (hypertension) High cholesterol (dyslipidemia) Type 2 diabetes Heart disease Obstructive sleep apnea Polycystic ovary syndrome ( PCOS ) In addition, in March 2024 the FDA expanded Wegovys approval to include reducing the risk of major cardiovascular events like heart attac k, stroke, and cardiovascular death in adults with cardiovascular disease plus overweight or obesity